119 related articles for article (PubMed ID: 37264612)
1. Leukocytosis and Splenomegaly in a Neonate With NRAS Mutation.
Lucena MH; Balasundaram P; Carney M; Green E; Breilyn MS; Fuloria M
Clin Pediatr (Phila); 2024 May; 63(4):451-455. PubMed ID: 37264612
[No Abstract] [Full Text] [Related]
2. Oculoectodermal Syndrome - Encephalocraniocutaneous Lipomatosis Associated with NRAS Mutation.
Richters RJH; Seyger MMB; Meeuwis KAP; Rinne T; Eijkelenboom A; Willemsen MA
Acta Derm Venereol; 2020 Apr; 100(8):adv00103. PubMed ID: 31633190
[No Abstract] [Full Text] [Related]
3. Detection of a multilineage mosaic NRAS mutation c.181C>A (p.Gln61Lys) in an individual with a complex congenital nevus syndrome.
Ulrich M; Tinschert S; Siebert E; Franke I; Tüting T; Ulrich J; Schanze D; Wieland I; Zenker M
Pigment Cell Melanoma Res; 2019 May; 32(3):470-473. PubMed ID: 30548225
[No Abstract] [Full Text] [Related]
4. An atypical chronic neutrophilic leukemia patient harboring ASXL1 and NRAS mutations associated with monoclonal plasma cell dyscrasia presenting as hemopericardium.
Han Q; Tao L; Jiang X; Chen H; Liu C; Sun M
Ann Hematol; 2021 Jan; 100(1):273-275. PubMed ID: 32052135
[No Abstract] [Full Text] [Related]
5. A postzygotic NRAS mutation in a patient with Schimmelpenning syndrome.
Kuroda Y; Ohashi I; Enomoto Y; Naruto T; Baba N; Tanaka Y; Aida N; Okamoto N; Niihori T; Aoki Y; Kurosawa K
Am J Med Genet A; 2015 Sep; 167A(9):2223-5. PubMed ID: 25914220
[No Abstract] [Full Text] [Related]
6. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia.
Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST
Pediatr Blood Cancer; 2016 Sep; 63(9):1667-70. PubMed ID: 27145535
[TBL] [Abstract][Full Text] [Related]
7. An NRAS mutation in a case of Erdheim-Chester disease.
Aitken SJ; Presneau N; Tirabosco R; Amary MF; O'Donnell P; Flanagan AM
Histopathology; 2015 Jan; 66(2):316-9. PubMed ID: 24754681
[No Abstract] [Full Text] [Related]
8. An acquired NRAS mutation contributes to neutrophilic progression in a patient with primary myelofibrosis.
Langabeer SE; Haslam K; Groarke E; Conneally E
Br J Haematol; 2018 Oct; 183(2):308-310. PubMed ID: 28961315
[No Abstract] [Full Text] [Related]
9. Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation.
Krengel S; Widmer DS; Kerl K; Levesque MP; Schiestl C; Weibel L
Br J Dermatol; 2016 Mar; 174(3):642-4. PubMed ID: 26302237
[No Abstract] [Full Text] [Related]
10. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
11. BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study.
Frank GA; Aleksakhina SN; Zavalishina LE; Kekeyeva TV; Venina AR; Ivantsov AO; Mitiushkina NV; Moiseyenko AV; Pfeifer W; Strelkova TN; Imyanitov EN
Melanoma Res; 2016 Oct; 26(5):442-7. PubMed ID: 27433783
[No Abstract] [Full Text] [Related]
12. Coexisting KRAS and NRAS mutations in colon cancer.
Sorscher S
J Clin Pathol; 2015 Dec; 68(12):1044. PubMed ID: 26243064
[No Abstract] [Full Text] [Related]
13. Bevacizumab-based treatment in colorectal cancer with a NRAS Q61K mutation.
Janku F; Wheler JJ; Hong DS; Kurzrock R
Target Oncol; 2013 Sep; 8(3):183-188. PubMed ID: 23400451
[TBL] [Abstract][Full Text] [Related]
14. Development of BRAF V600E Mutation in NRAS Q61L Mutated Rectal Cancer.
Cao MN; Chen KT; Li QF; Wang L; Jin GW; Na RT; Ma J; Liu YT; Gao JL
Ann Clin Lab Sci; 2021 Mar; 51(2):262-266. PubMed ID: 33941568
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation.
Chang YI; Damnernsawad A; Allen LK; Yang D; Ranheim EA; Young KH; Zhang J; Kong G; Wang J; Liu Y; Fu HY; Yang CS; Guo J; Song H; Zhang J
Br J Haematol; 2014 Aug; 166(3):461-5. PubMed ID: 24697267
[No Abstract] [Full Text] [Related]
16. Dermoscopic features in BRAF and NRAS primary cutaneous melanoma: association with peppering and blue-white veil.
Gouillon L; Perier-Muzet M; Amini-Adle M; Poulalhon N; Debarbieux S; Boespflug A; Balme B; Depaepe L; Harou O; Lopez J; Bringuier PP; Ferraro-Peyret C; Maucort-Boulch D; Robinson P; Thomas L; Dalle S
J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):e57-e59. PubMed ID: 31442328
[No Abstract] [Full Text] [Related]
17. BRAF and NRAS Mutations are Not Mutually Exclusive in Melanoma and in Single Melanoma Cells.
Uguen A; Guéguen P; Talagas M; Costa S; De Braekeleer M; Marcorelles P
Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):e14-5. PubMed ID: 26317309
[No Abstract] [Full Text] [Related]
18. A case of donor cell leukemia driven by a de novo NRAS mutation with complex karyotype.
Jeong D; Gu JY; Seo MS; Lee JS; Chang YH; Seong MW; Yoon SS; Kim HK
Ann Hematol; 2023 Jul; 102(7):1951-1952. PubMed ID: 37256306
[No Abstract] [Full Text] [Related]
19. High specificity and sensitivity of NRAS Q61R immunohistochemistry (IHC) in melanomas.
Just PA; Pouliquen C; Audebourg A; Laurent-Roussel S; Carlotti A; Dupin N; Vacher-Lavenu MC; Vidaud M; Terris B; Pasmant E
J Am Acad Dermatol; 2016 Mar; 74(3):572-3. PubMed ID: 26892658
[No Abstract] [Full Text] [Related]
20. KIT, NRAS, and BRAF mutations in nail apparatus melanoma.
Dika E; Altimari A; Patrizi A; Gruppioni E; Fiorentino M; Piraccini BM; Misciali C; Barisani A; Fanti PA
Pigment Cell Melanoma Res; 2013 Sep; 26(5):758-60. PubMed ID: 23782496
[No Abstract] [Full Text] [Related]
[Next] [New Search]
